Austar Lifesciences Ltd. | Cash Flow
Fiscal year is January-December. All values HKD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
96,974.40
110,530.40
9,362.10
20,448.50
67,363.30
4,143.20
Depreciation, Depletion & Amortization
7,704.10
9,929.80
12,882.50
13,400.60
10,042.20
11,366
Other Funds
19,716.90
47,613.90
-
-
-
3,431.40
Funds from Operations
83,985.00
81,254.40
14,082.60
10,029.70
45,320.90
12,077.90
Changes in Working Capital
8,416.90
157,815.80
86,154.90
57,941.90
36,690.10
1,647.60
Net Operating Cash Flow
92,401.90
76,561.40
100,237.60
47,912.20
8,630.90
13,725.50
Capital Expenditures
14,868.10
15,615.80
17,920.00
14,645.00
11,012.00
Sale of Fixed Assets & Businesses
46.70
124.60
19.70
763.00
2,373.10
Purchase/Sale of Investments
33,139.00
31,463.20
-
59,847.60
-
Net Investing Cash Flow
57,111.70
15,972.00
36,349.40
72,190.70
8,638.90
Cash Dividends Paid - Total
-
7,537.30
24,984.20
-
-
Issuance/Reduction of Debt, Net
5,046.90
18,877.90
-
17,526.30
-
Net Financing Cash Flow
14,670.00
366,059.70
24,984.20
17,526.30
-
Net Change in Cash
49,946.40
305,252.60
34,553.50
138,554.60
16,347.30
Free Cash Flow
78,461.20
91,373.00
82,754.20
60,781.10
19,120.50
Other Sources
-
-
1,650.40
1,538.80
-
Change in Capital Stock
-
402,333.00
-
-
-
Exchange Rate Effect
13.90
217.70
4,350.50
925.40
922.50
Other Uses
9,151.20
-
20,099.60
-
-
About Austar Lifesciences
View Profile
